Neurobiology of animal models of attention-deficit hyperactivity disorder

被引:98
|
作者
Russell, Vivienne Ann [1 ]
机构
[1] Univ Cape Town, Fac Hlth Sci, Dept Human Biol, ZA-7925 Observatory, South Africa
基金
英国医学研究理事会;
关键词
norepinephrine; dopamine; attention; hyperactivity; SHR; thyroid hormone;
D O I
10.1016/j.jneumeth.2006.12.005
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Attention-deficit hyperactivity disorder (ADHD) is a heterogeneous, highly heritable, disorder resulting from complex gene-gene and gene-environment interactions. The defining symptoms of hyperactivity, impulsivity and impaired sustained attention are not unique to ADHD. It is therefore not surprising that animals with distinctly different neural defects model the behavioural characteristics of the disorder. Consistent with ADHD being a developmental disorder, animal models are either genetic (spontaneously hypertensive rats (SHR), dopamine transporter (DAT) knock-out mice, SNAP-25 mutant mice, mice expressing a mutant thyroid receptor) or have suffered an insult to the central nervous system during the early stages of development (anoxia, 6-hydroxydopamine). It appears that neural transmission is impaired by either direct disruption of dopaminergic transmission or a more general impairment of neurotransmission that gives rise to compensatory changes in monoaminergic systems that are not sufficient to completely normalize neural function. In general, results obtained with animal studies suggest that dopamine neurons are functionally impaired. However, evidence obtained from some animal models suggests that the noradrenergic and serotonergic neurotransmitter systems may be the target of drugs that ameliorate ADHD symptoms. (C) 2007 Elsevier B.V. All rights reserved.
引用
收藏
页码:185 / 198
页数:14
相关论文
共 50 条
  • [41] Attention-deficit hyperactivity disorder
    不详
    POSTGRADUATE MEDICINE, 1996, 100 (03) : 338 - 338
  • [42] Attention-deficit hyperactivity disorder
    Hirsch, GS
    Koplewicz, HS
    EPILEPSY AND DEVELOPMENTAL DISABILITIES, 2002, : 187 - 204
  • [43] Attention-deficit/hyperactivity disorder
    Stephen V. Faraone
    Philip Asherson
    Tobias Banaschewski
    Joseph Biederman
    Jan K. Buitelaar
    Josep Antoni Ramos-Quiroga
    Luis Augusto Rohde
    Edmund J. S. Sonuga-Barke
    Rosemary Tannock
    Barbara Franke
    Nature Reviews Disease Primers, 1
  • [44] Attention-deficit/hyperactivity disorder
    Nature Reviews Disease Primers, 10
  • [45] ATTENTION-DEFICIT HYPERACTIVITY DISORDER
    WEISS, G
    CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE, 1993, 38 (06): : 443 - 443
  • [46] ATTENTION-DEFICIT HYPERACTIVITY DISORDER
    STEIN, MA
    LEVENTHAL, BL
    NEW ENGLAND JOURNAL OF MEDICINE, 1993, 329 (13): : 966 - 966
  • [47] Attention-Deficit/Hyperactivity Disorder
    Rajaprakash, Meghna
    Leppert, Mary L.
    PEDIATRICS IN REVIEW, 2022, 43 (03) : 135 - 147
  • [48] Attention-Deficit Hyperactivity Disorder
    Bahn, Geon-Ho
    JOURNAL OF THE KOREAN MEDICAL ASSOCIATION, 2005, 48 (11): : 1110 - 1118
  • [49] Attention-deficit/hyperactivity disorder
    Petermann, Franz
    Hampel, Petra
    KINDHEIT UND ENTWICKLUNG, 2009, 18 (03): : 135 - 136
  • [50] Attention-deficit/hyperactivity disorder
    Spencer, TJ
    ARCHIVES OF NEUROLOGY, 2002, 59 (02) : 314 - 316